Moxibustion for Fetus in Breech Presentation
|ClinicalTrials.gov Identifier: NCT00890474|
Recruitment Status : Completed
First Posted : April 29, 2009
Last Update Posted : April 29, 2009
Objective: To evaluate moxibustion of the BL67 acupoint between 34 and 38 weeks of gestation to facilitate cephalic version of breech presentation in a Western setting. The hypothesis is that moxibustion increase the likelihood of cephalic version.
Design: Randomised controlled trial Setting: University hospital. Population: A total of 212 consenting women between 34 and 36 weeks of gestation with a single fetus in breech presentation will be randomised to moxibustion (n=106) or expectant management (n=106).
Main Outcome Measure: Cephalic presentation at delivery or before external cephalic version.
|Condition or disease||Intervention/treatment||Phase|
|Breech Presentation||Procedure: Moxibustion of the BL67 acupoint||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||212 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Care Provider)|
|Official Title:||Moxibustion for Fetus in Breech Presentation|
|Study Start Date :||October 2004|
|Primary Completion Date :||December 2008|
|Study Completion Date :||January 2009|
Procedure: Moxibustion of the BL67 acupoint
Moxibustion sessions every day (every other day in hospital, self-administration at home the other day) during a maximum of 14 days. Stopped if cephalic version.
|No Intervention: Control|
- Cephalic presentation at delivery or before external cephalic version [ Time Frame: end of pregnancy ]
- Mode of delivery [ Time Frame: end of pregnancy ]
- Women's views on the intervention [ Time Frame: end of pregnancy ]
- External cephalic version [ Time Frame: end of pregnancy ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00890474
|Hôpitaux Universitaires de Genève|